JSA advised Equirus Capital Private Limited, Ambit Private Limited and Nuvama Wealth Management Limited (the book running lead managers) in relation to the initial public offering of equity shares of Senores Pharmaceuticals Limited (“Company”) aggregating to ₹ 5,821.10 million comprising a fresh issue of ₹ 5,000 million and an offer for sale of ₹ 821.10 million by certain selling shareholders of the Company.
Our Transaction Team Comprised Lead Partner – Arka Mookerjee, Partner – Siddhartha Desai, and Associate – Govind Roy, Anvita Sinha and Prateek Khandelwal.
Arka Mookerjee is a Partner and Co-Head of the Equity Capital Markets practice, with over 21 years of experience advising on India’s most complex and high-value transactions. Widely recognised for pioneering mandates—including India’s first QIP and InvIT IPO—he represents issuers, underwriters and investors across capital markets and investment structures. Arka actively engages with regulators and industry bodies, playing a key role in shaping India’s evolving capital markets framework.